Explore Our Cell and Gene Therapy CDMO Solutions
High Quality Plasmid DNA: A Case for Phase Dependent Approaches to Manufacturing
Learn about the technical challenges around plasmid production and emerging regulatory guidelines.
Cell and Gene Therapy Development Video Series
In these videos, our experts describe critical considerations, key strategies, and the technologies that can make your program a success.
Gene Therapy, A Promising Future for Epileptic Drug Development
Cobra Biologics, now a Charles River company, and partner, CombiGene AB recently announced the successful completion of the production of plasmids for use in the treatment of drug-resistant focal epilepsy (CombiGene project CG01).
Tailored Preclinical Support for Your Cell & Gene Therapies
The complexity of cell and gene therapies, combined with limited regulatory precedent, makes these treatments especially challenging to develop. With the right partner, however, there’s no need to reinvent the wheel. See how we can help you design and execute a robust, efficient program that delivers accurate data to authorities.